Marine derived drugs industry Would be bound to emerge in terms of biomaterials and supplements in 2022

About This Presentation
Title:

Marine derived drugs industry Would be bound to emerge in terms of biomaterials and supplements in 2022

Description:

Marine Derived Drugs -Market Competition by Manufacturers,Manufacturers Profiles/Analysis,Manufacturing Cost Analysis,Industrial Chain,Sourcing Strategy and Downstream Buyers, Market Effect Factors Analysis – PowerPoint PPT presentation

Number of Views:27

less

Transcript and Presenter's Notes

Title: Marine derived drugs industry Would be bound to emerge in terms of biomaterials and supplements in 2022


1
Marine Derived Drugs Market may witness new
avenues in the global healthcare industry by 2022
Marine Derived Drugs Market Contains Market
Competition by Manufacturers, Manufacturers
Profiles/Analysis, and Manufacturing Cost
Analysis, Industrial Chain, Sourcing Strategy and
Downstream Buyers, Market Effect Factors
Analysis.
Marine species can now be used for medication
purposes and so the research continues. Marine
derived compounds are more bioactive than any
other species particularly in terms of
cytotoxicity. Marine natural products have a
stronghold in the domain of anticancer
chemotherapy as indicated by researchers. Such
compounds have already made to the market or are
under clinical research. On the basis of
geographic segmentation, the global marine
derived drugs market is segmented into North
America, Europe, Asia Pacific, and Middle-East
Africa. Till date, global marine pharmaceutical
drugs consist of seven approved pharmaceuticals
in clinical use, four of which are anticancer
drugs. Cytarabine or Ara-C is the first
marine-derived anticancer agent to be developed
for clinical use and is a synthetic analogue of a
C-nucleoside from Caribbean sponge. Second
anticancer marine drug found was tunicate
Ecteinascidia turbinate would be utilized Browse
Full Research Report of Marine Derived Drugs
Market _at_ https//www.millioninsights.com/industry
-reports/marine-derived-drugs-market
2
for treatment of soft tissue sarcomas and ovarian
cancer. The third marine anti-cancer drug was
halichondria okadai which is a simpler structure
comprising pharmacophore obtained
synthetically. Eribulin (Halaven) is the most
complex marine drug made till date and is used
for the treatment of drug refractory breast
cancer. The recently approved marine drug namely
brentuximab vedotin (Adcetris) is a chimeric
antibody coupled with protease-cleavable linker
to a derivative of the dolastatin to treat
hodgkins lymphomas and large cell lymphoma.
Thus, marine derived drugs are also found in
antiviral drugs to treat various kinds of
infections. Much recently, there have been drugs
developments for Anticancer, Alzheimers disease,
and are also used as Antibacterials. Aplidine,
Plinabulin and Salinosporamide A have been found
for anticancer whereas Bryostatin for Alzheimers
and Anthracimycin as an Antibacterial. Commercial
ly, the rising healthcare requirements and the
unmet needs are to be addressed by innovative
methods. Developed nations have already started
taking initiatives in this direction to resolve
critical illness using marine compounds. If the
research is conducted on a large scale and in
joint venture, the global market may witness new
avenues in the global healthcare
industry. Request Sample Copy of this Market
Research _at_ https//www.millioninsights.com/industr
y-reports/marine-derived-drugs-market/request-samp
le The key driving factors responsible for the
growth of marine derived drugs market include
growing initiatives for preserving marine
biodiversity and investments in research programs
worldwide. Additionally, several companies are
now gearing up to research various compounds that
can cure several disease and illnesses.
Industries are now aiming to determine marine
organisms and are working towards finding a cure
for fatal and high-risk disease in upcoming
years. However, less research conducted to study
marine elements for clinical purpose is likely to
impede the market growth during the forecast
period. Hence, with the prediction for estimated
period, the global marine derived drugs industry
is bound to emerge in terms of production of
drugs, biomaterials and supplements. North
America and Europe are anticipated to dominate
the global marine derived drugs market during the
forecast period owing to the sophisticated
infrastructure of healthcare and also due to high
awareness with regards to chronic ailments.
3
  • APAC regions such as India and China are
    anticipated to grow at a higher CAGR during the
    forecast period owing to lucrative opportunities
    for the global marine derived drugs market. Also
    the rise in medical tourism in India and China
    have made them popular destinations for advanced
    medical care, leading to rise in increasing
    number of patients from underdeveloped regions.
    The key players in the global marine derived
    drugs market include Pharma Marine USA, Genzyme,
    Bayer Innovation, Abbott Laboratories, Takeda
    Oncologys Millennium LLC, Marine Polymer
    Technologies, Inc., and Xenome Limited.
  • Market Segment
  • Geographically, this report is segmented into
    several key Regions, with production,
    consumption, revenue (million USD), market share
    and growth rate of Marine Derived Drugs in these
    regions, from 2012 to 2022 (forecast), covering
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • See More Reports of this Category by Million
    Insights _at_ https//www.millioninsights.com/indust
    ry/pharmaceuticals
  • Global Marine Derived Drugs market competition by
    top manufacturers, with production, price,
    revenue (value) and market share for each
    manufacturer the top players including
  • Pharma Marine USA
  • Genzyme
  • Bayer Innovation
  • Abbott Laboratories
  • Takeda Oncology's Millennium
  • Marine Polymer Technologies
  • Xenome Limited

4
  • On the basis of product, this report displays the
    production, revenue, price, market share and
    growth rate of each type, primarily split into
  • Phenols
  • Steroids
  • Ethers
  • Strigolactones
  • Peptides
  • Marine Microorganisms
  • Marine Algae
  • Marine Invertebrates
  • On the basis on the end users/applications, this
    report focuses on the status and outlook for
    major applications/end users, consumption
    (sales), market share and growth rate of Marine
    Derived Drugs for each application, including
  • Antimicrobials
  • Antitumor Drugs
  • Anti-Cardiovascular Drugs
  • Antiviral Drugs
  • Digestive System Drugs
  • Anti-Inflammatory Analgesic Drugs
  • Urinary System Drugs
  • Functional Food
  • Browse Full Research Report of Marine Derived
    Drugs Market _at_ https//www.millioninsights.com/in
    dustry-reports/marine-derived-drugs-market

5
Get in touch At Million Insights, we work with
the aim to reach the highest levels of customer
satisfaction. Our representatives strive to
understand diverse client requirements and cater
to the same with the most innovative and
functional solutions. Contact Person Ryan
Manuel Research Support Specialist, USA Email
ryan_at_millioninsights.com
Global Headquarters Million Insights
Asia Pacific Million Insights
Felton Office Plaza 6265 Highway 9 Felton,
California 95018, United States
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, MH, 411016
India
Phone 1-408-610-2300 Email sales_at_millioninsights
.com
Phone 91-20-65300184 Email sales_at_millioninsights
.com
Visit Our Blog
www.millioninsights.blogspot.com
Write a Comment
User Comments (0)